USE OF CHIMERICAL ANTIGEN RECEPTOR T LYMPHOCYTES AND NK CELL INHIBITORS FOR CANCER TREATMENT

MA56388AUndetermined Publication Date: 2022-05-04CRISPR THERAPEUTICS AG

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA56388
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2019-12-20
Filing Date: 2020-06-26
Publication Date: 2022-05-04

Application Information

Patent Timeline

20 Dec 2019

Priority

26 Jun 2020

Application

MA56388

04 May 2022

Publication

MA56388A

IPC: A61K39/00; A61P35/00; C07K14/725

CPC: C07K14/7051; A61P35/00; A61K2300/00; A61K2039/505; A61K2039/804; C07K2317/21; C07K16/2896; C07K16/2878

Inventors: KLEIN Lawrence; MORAWA Ewelina

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.